DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia

被引:100
作者
Lie, AK
Risberg, B
Borge, B
Sandstad, B
Delabie, J
Rimala, R
Onsrud, M
Thoresen, S
机构
[1] Norwegian Radium Hosp, Dept Pathol, Oslo, Norway
[2] Norwegian Canc Soc, Oslo, Norway
[3] Pathol Lab, Oslo, Norway
[4] Ullevaal Univ Hosp, Dept Gynecol, Oslo, Norway
[5] Canc Registry Norway, Inst Epidemiol Canc Res, Oslo, Norway
关键词
HPV; DNA; mRNA; CIN; carcinoma;
D O I
10.1016/j.ygyno.2005.02.026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To compare DNA-based and mRNA-based methods for detection of high-grade cervical neoplasia in Norway. Methods. HPV prevalence was analyzed in 383 women with positive index cytology, selected from gynecology clinics. All patients were investigated by a new PAP smear, histology, and two commercially available HPV tests: Hybrid Capture II (Digene, Gaithersburg, MD) and the Pre Tect HPV-Proofer (NorChip AS). Cases with positive DNA test and negative mRNA test and cases with high-grade histology and negative HPV tests were retested with PCR and sequencing. We regarded the infection as latent or transient if sequencing revealed an HPV type included in both assays. Results. High-risk HPV was detected in 99.7% of the histological confirmed high-grade lesions (CIN2+) (290/291). The DNA test was positive in 95% (275/291), and the mRNA test was positive in 77% (225/291) of the histological confirmed high-grade lesions. All invasive carcinomas were mRNA positive. The DNA test was significantly more often positive in benign and low-grade lesions, some of which were found to be false positive due to cross-contamination with unrelated types. High-grade histology was detected in 83% of women with normal cytology and positive mRNA test. Latent or transient infections were detected in 11 low-grade and 12 high-grade preinvasive lesions. Sequencing revealed high-risk HPV types included only in the DNA test in 35 high-grade preinvasive lesions, HPV 52 and 58 were the most prevalent HPV types. Conclusions. These HPV tests have the potential to improve the detection rate of high-grade cervical neoplasia, with some limitations. The mRNA test seems to be more appropriate for risk-evaluation. Larger scale, population based studies are necessary to evaluate the predictive values of HPV testing in Norway. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:908 / 915
页数:8
相关论文
共 50 条
  • [41] Human Papillomavirus and Cervical Neoplasia Among Female Sex Workers in Madagascar
    Smith, Jennifer S.
    Van Damme, Kathleen
    Randrianjafisamindrakotroka, Nantenaina
    Ting, Jie
    Rabozakandraina, Tiana
    Randrianasolo, Bodo S.
    Raharinivo, Mbolatiana
    Zanasaotra, Sandrine
    Hobbs, Marcia
    Rinas, Allen
    Cohen, Myron
    Gravitt, Patti
    Behets, Frieda
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (09) : 1593 - 1596
  • [42] Distribution of human papillomavirus in precancerous and cancerous cervical neoplasia in Tunisian women
    Rhouma, Rahima Bel Haj
    Ardhaoui, Monia
    El Fehri, Emna
    Marzougui, Asma
    Laassili, Thalja
    Guizani, Ikram
    Boubaker, Med Samir
    Ennaifer, Emna
    INFECTIOUS AGENTS AND CANCER, 2021, 16 (01)
  • [43] DNA/RNA-based formulations for treatment of breast cancer
    Xie, Zhaolu
    Zeng, Xianghui
    EXPERT OPINION ON DRUG DELIVERY, 2017, 14 (12) : 1379 - 1393
  • [44] Human papillomavirus type specific DNA and RNA persistence - Implications for cervical disease progression and monitoring
    Cuschieri, KS
    Whitley, MJ
    Cubie, HA
    JOURNAL OF MEDICAL VIROLOGY, 2004, 73 (01) : 65 - 70
  • [45] The advent of human papillomavirus detection for cervical screening
    Morris, Brian J.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2019, 31 (05) : 333 - 339
  • [46] Molecular detection of human papillomavirus and viral DNA load after radiotherapy for cervical carcinomas
    Kahla, Saloua
    Kochbati, Lotfi
    Sarraj, Sana
    Ben Daya, Imen
    Maalej, Mongi
    Oueslati, Ridha
    TUMORI JOURNAL, 2016, 102 (05): : 521 - 526
  • [47] Human Papillomavirus DNA Presence in Pelvic Lymph Nodes in Cervical Cancer
    Slama, Jiri
    Fischerova, Daniela
    Pinkavova, Ivana
    Zikan, Michal
    Cibula, David
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (01) : 126 - 132
  • [48] Role of human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia
    Huang, Huei-Jean
    Tung, Hsiu-Jung
    Yang, Lan-Yan
    Chao, Angel
    Tang, Yun-Hsin
    Chou, Hung-Hsueh
    Chang, Wei-Yang
    Wu, Ren-Chin
    Huang, Chu-Chun
    Lin, Chiao-Yun
    Liao, Min-Jie
    Chen, Wei-Chun
    Lin, Cheng-Tao
    Chen, Min-Yu
    Huang, Kuan-Gen
    Wang, Chin-Jung
    Chang, Ting-Chang
    Lai, Chyong-Huey
    INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (03) : 665 - 672
  • [49] Detection Rate of High-Grade Cervical Neoplasia and Cost-Effectiveness of High-Risk Human Papillomavirus Genotyping with Reflex Liquid-based Cytology in Cervical Cancer Screening
    Tay, Sun Kuie
    Lin, Lynette E. O.
    Goh, Ronald C. H.
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2017, 46 (07) : 267 - 273
  • [50] Ki-67 Quantitative Evaluation as a Marker of Cervical Intraepithelial Neoplasia and Human Papillomavirus Infection
    Mimica, Marko
    Tomic, Snjezana
    Kardum, Goran
    Hofman, Irena Drmic
    Kaliterna, Vanja
    Pejkovic, Lidija
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (01) : 116 - 119